Patents by Inventor David H. Gelfand

David H. Gelfand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5968799
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermosipho africanus. The enzyme has DNA polymerase, activity reverse transcriptase activity, and optionally 5'.fwdarw.3' and/or 3'.fwdarw.5' exonuclease activity. The enzyme can be native or recombinant, and may be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: February 9, 1993
    Date of Patent: October 19, 1999
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, I. Lawrence Greenfield, Fred L. Reichert
  • Patent number: 5804375
    Abstract: A process of detecting a target nucleic acid using labeled oligonucleotides uses the 5' to 3' nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and release labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification assay.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: September 8, 1998
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Pamela M. Holland, Randall K. Saiki, Robert M. Watson
  • Patent number: 5795762
    Abstract: The present invention relates to thermostable DNA polymerases which exhibit a different level of 5' to 3' exonuclease activity than their respective native polymerases. Particular conserved amino acid domains in thermostable DNA polymerases are mutated or deleted to alter the 5' to 3' exonuclease activity of the polymerases. The present invention also relates to means for isolating and producing such altered polymerases.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: August 18, 1998
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Richard D. Abramson, David H. Gelfand
  • Patent number: 5789224
    Abstract: Recombinant DNA sequences encoding the DNA polymerase activity of Thermus thermophilus can be used to construct recombinant vectors and transformed host cells for production of the activity. T. thermophilus DNA polymerase is an .about.94 kDa protein especially useful in the DNA amplification procedure known as the polymerase chain reaction.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: August 4, 1998
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5759828
    Abstract: The present invention provides the nucleotide sequences of Acetobacter operons, cdg operons encoding genes for the biosynthesis and degradation of cyclic diguanosine monophosphate (c-di-GMP). Specifically, the nucleotide sequences and deduced amino acid sequences of 3 phosphodiesterases isozymes, 3 diguanylate cyclase isozymes, and 2 polypeptides of unidentified function are provided. Also provided for are various strains of microorganisms, including Acetobacter cells genetically manipulated so as to produce elevated and/or reduced levels of one or more cdg operon encoded proteins.
    Type: Grant
    Filed: September 20, 1994
    Date of Patent: June 2, 1998
    Assignee: Weyerhaeuser
    Inventors: Rony Tal, David H. Gelfand, Roger D. Calhoon, Arie Ben-Bassat, Moshe Benziman, Hing Cheung Wong
  • Patent number: 5693517
    Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. In a preferred embodiment, high temperature reverse transcription is coupled to nucleic acid amplification in a one tube, one enzyme procedure using a thermostable DNA polymerase. Methods for eliminating carry over contamination of amplifications due to prior reverse transcription reactions are also provided. Reagents particularly suited for the methods of the present invention are provided.
    Type: Grant
    Filed: February 2, 1995
    Date of Patent: December 2, 1997
    Assignee: Roche Molecular Systems, Inc.
    Inventors: David H. Gelfand, Thomas W. Myers, Christopher L. Sigua
  • Patent number: 5674738
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermus species Z05. The enzyme has DNA polymerase, activity reverse transcriptase activity, and optionally 5'.fwdarw.3' exonuclease activity. The enzyme can be native or recombinant, and may be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: August 29, 1995
    Date of Patent: October 7, 1997
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Richard D. Abramson, David H. Gelfand, I. Lawrence Greenfield
  • Patent number: 5641864
    Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. In a preferred embodiment, high temperature reverse transcription is coupled to nucleic acid amplification in a one tube, one enzyme procedure using a thermostable DNA polymerase. Methods for eliminating carry over contamination of amplifications due to prior reverse transcription reactions are also provided.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: June 24, 1997
    Assignee: Hoffman-La Roche Inc.
    Inventor: David H. Gelfand
  • Patent number: 5624833
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermotoga maritima. The enzyme has a molecular weight as determined by gel electrophoresis of about 97 kilodaltons and DNA polymerase I activity. The enzyme can be produced from native or recombinant host cells and can be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 29, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5618711
    Abstract: Recombinant DNA sequences encoding the DNA polymerase activity of Thermus thermophilus can be used to construct recombinant vectors and transformed host cells for production of the activity. T. thermophilus DNA polymerase is an .about.94 kDa protein especially useful in the DNA amplification procedure known as the polymerase chain reaction.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: April 8, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5618703
    Abstract: Methods are provided for distinguishing between RNA and DNA templates in an amplification reaction. In a preferred embodiment of the invention, the amplification reaction is a PCR and the reaction is catalyzed by a thermostable DNA polymerase or both reverse transcription and amplification of a target RNA. The invention particularly relates to selective amplification of RNA in the presence of homologous DNA, for example, HIV nucleic acids.
    Type: Grant
    Filed: February 22, 1994
    Date of Patent: April 8, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Thomas W. Myers
  • Patent number: 5561058
    Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. In a preferred embodiment, high temperature reverse transcription is coupled to nucleic acid amplification in a one tube, one enzyme procedure using a thermostable DNA polymerase. Methods for eliminating carry over contamination of amplifications due to prior reverse transcription reactions are also provided. Reagents particularly suited for the methods of the present invention are provided.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: October 1, 1996
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Thomas W. Myers, Christopher L. Sigua
  • Patent number: 5491086
    Abstract: Recombinant DNA sequences encoding the DNA polymerase activity of Pyrodictium species can be used to construct recombinant vectors and transformed host cells for production of the activity. Pyrodictium enzymes for catalyzing 3'.fwdarw.5' exonuclease activity, i.e., proofreading enzymes, are also provided. The Pyrodictium enzymes are useful in DNA amplification procedures and are not irreversibly inactivated by exposure to 100.degree. C. in a polymerase chain reaction.
    Type: Grant
    Filed: May 14, 1993
    Date of Patent: February 13, 1996
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Alice M. Wang
  • Patent number: 5487972
    Abstract: A process of detecting a target nucleic acid using labeled oligonucleotides which uses the 5' to 3' nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and thus releasing labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification assay.
    Type: Grant
    Filed: January 5, 1993
    Date of Patent: January 30, 1996
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Pamela M. Holland, Randall K. Saiki, Robert M. Watson
  • Patent number: 5466591
    Abstract: The present invention relates to thermostable DNA polymerases which have been mutated such that a lesser amount of 5' to 3' exonuclease activity is exhibited from that which is exhibited by the native enzyme.
    Type: Grant
    Filed: February 23, 1993
    Date of Patent: November 14, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Richard D. Abramson, David H. Gelfand
  • Patent number: 5455170
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermus species Z05. The enzyme has DNA polymerase, activity reverse transcriptase activity, and optionally 5'.fwdarw.3' exonuclease activity. The enzyme can be native or recombinant, and may be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: August 27, 1993
    Date of Patent: October 3, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Richard D. Abramson, David H. Gelfand, I. Lawrence Greenfield
  • Patent number: 5420029
    Abstract: A purified thermostable enzyme is derived from the eubacterium Thermotoga maritima. The enzyme has a molecular weight as determined by gel electrophoresis of about 97 kilodaltons and DNA polymerase I activity. The enzyme can be produced from native or recombinant host cells and can be used with primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: February 3, 1993
    Date of Patent: May 30, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Frances C. Lawyer, Susanne Stoffel
  • Patent number: 5418149
    Abstract: Improved methods for amplifying nucleic acids can reduce non-specific amplification and minimize the effects of contamination of nucleic acid amplification reaction assays due to amplified product from previous amplifications. The methods involve the introduction of unconventional nucleotide bags into the amplification reaction products and treating the products by enzymatic (e.g., glycosylases) and/or physical-chemical means to render the product incapable of acting as a template for subsequent amplifications.
    Type: Grant
    Filed: January 5, 1993
    Date of Patent: May 23, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Shirley Y. Kwok, John J. Sninsky
  • Patent number: 5407800
    Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. Reverse transcription of RNA is catalyzed by, for example, 94 kDa Taq, 62 kDa Taq, and recombinant Tth DNA polymerase. Reverse transcription is coupled to PCR amplification in a one enzyme procedure using a thermostable polymerase.
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: April 18, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David H. Gelfand, Thomas W. Myers
  • Patent number: 5405774
    Abstract: A purified thermostable enzyme is derived from the bacterium Thermus species sps17. The enzyme has DNA polymerase activity, reverse transcriptase activity, and optionally, 5'.fwdarw.3' exonuclease activity. The enzyme can be native or recombinant, and can be used with selected primers and nucleoside triphosphates in a temperature-cycling chain reaction where at least one nucleic acid sequence is amplified in quantity from an existing sequence.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: April 11, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Richard D. Abramson, David H. Gelfand, I. Lawrence Greenfield